The purpose of this study is to visualize and quantify ER-binding sites during treatment with Elacestrant (RAD1901) using 16α-18F-Fluoro-17β-estradiol (FES) positron emission tomography (PET) imaging
The purpose of this study is to visualize and quantify ER-binding sites during treatment with Elacestrant (RAD1901)